Nu-Med Plus (NUMD) Cash from Operations (2012 - 2025)

Nu-Med Plus has disclosed Cash from Operations across 14 years of filings, most recently posting 35054.0 for Q4 2025.

• Cash from Operations for Q4 2025 came in at 35054.0, down 2001.56% year-over-year; the trailing twelve-month figure through Dec 2025 was 48137.0 (down 985.88% YoY), and the FY2025 annual result was 47979.0, down 982.31% from the prior year.
• Cash from Operations came in at 35054.0 for Q4 2025 at Nu-Med Plus, down from 11415.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 628.0 in Q3 2022 to a low of 79241.0 in Q1 2021.
• The 5-year median for Cash from Operations is 18869.0 (2023), against an average of 21329.53.
• Across the five-year window, Cash from Operations surged 101.53% in 2022 and plunged 3104.62% in 2023, its largest moves.
• Nu-Med Plus' Cash from Operations stood at 20165.0 in 2021, then fell by 21.17% to 24433.0 in 2022, then jumped by 82.47% to 4282.0 in 2023, then soared by 61.05% to 1668.0 in 2024, then tumbled by 2001.56% to 35054.0 in 2025.
• The last three Cash from Operations figures came in at 35054.0 (Q4 2025), 11415.0 (Q3 2025), and 1668.0 (Q4 2024), per Business Quant data.